Stephen Eeden to Disease Progression
This is a "connection" page, showing publications Stephen Eeden has written about Disease Progression.
Connection Strength
0.503
-
Selecting Active Surveillance: Decision Making Factors for Men with a Low-Risk Prostate Cancer. Med Decis Making. 2019 11; 39(8):962-974.
Score: 0.079
-
PROspective Evaluation of Chronic Pancreatitis for EpidEmiologic and Translational StuDies: Rationale and Study Design for PROCEED From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer. Pancreas. 2018 Nov/Dec; 47(10):1229-1238.
Score: 0.074
-
Identification of fluorescence in situ hybridization assay markers for prediction of disease progression in prostate cancer patients on active surveillance. BMC Cancer. 2018 01 02; 18(1):2.
Score: 0.070
-
A Biopsy-based 17-gene Genomic Prostate Score as a Predictor of Metastases and Prostate Cancer Death in Surgically Treated Men with Clinically Localized Disease. Eur Urol. 2018 01; 73(1):129-138.
Score: 0.069
-
Sociodemographic and Clinical Predictors of Switching to Active Treatment among a Large, Ethnically Diverse Cohort of Men with Low Risk Prostate Cancer on Observational Management. J Urol. 2016 Sep; 196(3):734-40.
Score: 0.062
-
Progression and treatment of incident lower urinary tract symptoms (LUTS) among men in the California Men's Health Study. BJU Int. 2015 Jan; 115(1):127-33.
Score: 0.055
-
Efficacy of intermittent androgen deprivation therapy vs conventional continuous androgen deprivation therapy for advanced prostate cancer: a meta-analysis. Urology. 2013 Aug; 82(2):327-33.
Score: 0.052
-
Incidence of and risk factors for change in urinary incontinence status in a prospective cohort of middle-aged and older women: the reproductive risk of incontinence study in Kaiser. J Urol. 2010 Oct; 184(4):1394-401.
Score: 0.042